Investigates METTL14's role in regulating apoptosis and invasion in osteosarcoma, suggesting new therapeutic targets.
Osteosarcoma (OS) is a highly aggressive mesenchymal bone tumor with a dismal prognosis, and its underlying molecular mechanisms remain elusive. Ribosomal protein L13a (RPL13a) contributes to tumorigenesis, while methyltransferase‐like 14 (METTL14), a core m 6 A methyltransferase, modulates OS progression via epigenetic regulation. Our prior work identified the PTEN/PI3K/AKT pathway as a key OS regulator. This study aimed to clarify the regulatory interplay among METTL14, RPL13a and PTEN/PI3K/AKT in OS, and verify that METTL14 mediates RPL13a m 6 A modification to regulate PTEN/PI3K/AKT signaling, affecting OS cell proliferation, apoptosis, migration and invasion. METTL14, RPL13a and m 6 A levels were detected in OS cell lines (U2OS, HOS, MG‐63) and normal osteoblast hFOB1.19 cells. RPL13a knockdown, PTEN overexpression and METTL14 overexpression models were established in U2OS/HOS cells. M 6 A‐RIP‐qPCR and MeRIP assays confirmed RPL13a m 6 A modification, with functional (CCK‐8, flow cytometry, wound healing, Transwell) and molecular (RT‐qPCR, Western blotting) assays performed in triplicate replicates. METTL14 and RPL13a were upregulated in U2OS/HOS cells versus hFOB1.19 ( p < 0.05). METTL14 overexpression elevated RPL13a m 6 A modification by ~1.8‐fold ( p < 0.05); si‐RPL13a reduced RPL13a mRNA by > 60% ( p < 0.05). RPL13a knockdown promoted apoptosis, inhibited proliferation/migration/invasion, downregulated PTEN and activated PI3K/AKT signaling, partially reversed by PTEN overexpression. METTL14 overexpression upregulated RPL13a/PTEN and suppressed PI3K/AKT activation, abolished by RPL13a knockdown. METTL14 appears to mediate the m6A methylation modification of RPL13a mRNA. Downregulation of RPL13a is associated with reduced PTEN and activated PTEN/PI3K/AKT signaling, which may ultimately contribute to suppressed osteosarcoma cell proliferation, migration, and invasion while promoting apoptosis.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: